Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

24.17 -1.71 (-6.61%)
Streaming Delayed Price Updated: 3:16 PM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
52 53 Next >
News headline image
Hims & Hers, Salesforce, Omeros, United Airlines, And Sea Ltd: Why These 5 Stocks Are On Investors' Radars Today ↗
Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31. 
Via Benzinga
Topics Stocks
News headline image
Why Hims & Hers Stock Blasted 16% Higher on Wednesday ↗
Investors liked what they heard about the company's latest expansion of its business. 
Via The Motley Fool
News headline image
Investors Are Buying Hims & Hers Health Stock Following Wednesday's Platform Expansion Announcement ↗
Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Wednesday following the company's launch of a new menopause and perimenopause care specialty on its Hers platform. 
Via Benzinga
News headline image
Why Are Hims & Hers Health (HIMS) Shares Soaring Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 5.7% in the afternoon session after the company announced the launch of perimenopause and menopause treatment options on its platform.... 
Via StockStory
Topics Artificial Intelligence
Hims & Hers Health Brings Menopause, Perimenopause Treatments On Its Platform ↗
Via Stocktwits
News headline image
IBD 50's Hims & Hers Surges After Announcing A Menopause Care Launch ↗
Shares are nearing a buy point out of a cup-with-handle base. 
Via Investor's Business Daily
News headline image
Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026
From Hims & Hers
Via Business Wire
News headline image
Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock? ↗
Investors looking at the healthcare industry have two excellent choices with UnitedHealth and Hims & Hers. 
Via The Motley Fool
News headline image
Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025
From Hims & Hers
Via Business Wire
News headline image
HIMS & Hers Health Inc (NYSE:HIMS): A High-Growth Telehealth Stock Poised for a Breakout ↗
Discover how Hims & Hers Health (HIMS) combines explosive revenue growth with a bullish technical setup, making it a top telehealth stock to watch. 
Via Chartmill
News headline image
Why Hims & Hers Health (HIMS) Stock Is Nosediving
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.5% in the afternoon session after a Bank of America report highlighted weakening order trends and a lowered fourth-quarter revenue... 
Via StockStory
Topics World Trade
News headline image
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office
From Hims & Hers
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
HIMS & HERS HEALTH INC (NYSE:HIMS) Shows Strong Technical Setup Ahead of Potential Breakout ↗
HIMS stock shows strong technical momentum and a consolidation pattern, suggesting a potential breakout. The setup offers a clear risk/reward profile for technical traders. 
Via Chartmill
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Why Hims & Hers Stock Slipped Today ↗
Investors generally aren't fond of C-suite changes in relatively young businesses. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
HIMS & HERS HEALTH INC (NYSE:HIMS) Shows High-Growth Momentum and Technical Breakout Potential ↗
Hims & Hers (HIMS) is a high-growth momentum stock with strong earnings and a positive technical breakout setup, offering a compelling opportunity for investors. 
Via Chartmill
News headline image
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics World Trade
News headline image
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment ↗
 
Via Benzinga
News headline image
The Secret to Finding the Next Amazon Is Hiding in Plain Sight ↗
These innovators are disrupting massive industries with a customer-centric business strategy. 
Via The Motley Fool
Topics Retirement
Eli Lilly Stock Jumps As Trump’s Drug Price Crackdown Spurs Sector Rally; Analysts Say Pfizer Deal Sets Template For Big Pharma ↗
Via Stocktwits
Topics Government
News headline image
Six Stocks That Shocked Wall Street: Unpacking This Year's Surprise Market Winners
The year 2025 has unfolded with a compelling narrative of unexpected triumphs in the stock market, where several companies have defied conventional wisdom and analyst forecasts to emerge as significant... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Not Nearly Enough People Are Talking About Chewy Stock ↗
The company has multiple trends working in its favor. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks Using AI to Drive Growth ↗
AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Hims & Hers Powers YieldMax's Latest Options-Based Income ETF ↗
YieldMax ETFs grew its expanding lineup of income-oriented funds on Tuesday with the introduction of the YieldMax HIMS Option Income Strategy ETF (NYSE: HIYY). 
Via Benzinga
Topics ETFs
News headline image
A Healthcare Debate: Progyny vs. Hims & Hers ↗
Motley Fool analysts take a look. 
Via The Motley Fool
News headline image
1 Momentum Stock with Competitive Advantages and 2 We Find Risky
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
News headline image
2 Volatile Stocks Worth Investigating and 1 That Underwhelm
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
News headline image
I'm Downgrading Hims & Hers Stock ↗
The fast-growing company is taking investors on a roller-coaster ride. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
52 53 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.